Manufacturing’s Engagement Gap Is Creating Safety Risks on the Factory Floor
Manufacturers have spent millions investing in safer equipment, smarter automation, and increasingly sophisticated operational technology.
Manufacturers have spent millions investing in safer equipment, smarter automation, and increasingly sophisticated operational technology.
We often think of AI as a technological revolution that will transform industries, disrupt jobs, and change the nature of competitive advantage.
Midtier life sciences companies are spending more than ever on quality and regulatory technology, yet many are paying enterprise prices for capability they never use.
Teams building software as a medical device (SaMD) tend to think of ISO 14971 as the hardware team’s problem. Risk management files, FMEA tables, severity scores: all quality and regulatory territory, while the engineers close Jira tickets.
As we celebrate the United States’ 250th anniversary this year, NIST experts have been working to preserve our nat
As a significant portion of the experienced manufacturing workforce approaches retirement, companies face the critical threat of losing undocumented tribal knowledge.
For years, many medical device manufacturers approached U.S. Food and Drug Administration (FDA) inspections through a familiar lens: Prepare documents, review subsystem requirements, rehearse likely questions, and demonstrate compliance against a known framework.
As pharmaceutical manufacturers push toward lower detection limits, tighter impurity thresholds, and faster development cycles, elemental analysis has become a more critical part of quality and compliance.
In the larger organizations I worked for as a quality leader, supplier auditing was almost always calendar-driven.
© 2026 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute Inc.